Net Income (Loss) Attributable to Parent in USD of Bruker Cellular Analysis, Inc. from 2018 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Bruker Cellular Analysis, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from 2018 to Q2 2023.
  • Bruker Cellular Analysis, Inc. Net Income (Loss) Attributable to Parent for the quarter ending 30 Jun 2023 was -$50.2M, a 95.1% decline year-over-year.
  • Bruker Cellular Analysis, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending 30 Jun 2023 was -$125M, a 46% decline year-over-year.
  • Bruker Cellular Analysis, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$98M, a 36.7% decline from 2021.
  • Bruker Cellular Analysis, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$71.7M, a 72.5% decline from 2020.
  • Bruker Cellular Analysis, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$41.6M, a 127% decline from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

Bruker Cellular Analysis, Inc. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 -$125M -$50.2M -$24.5M -95.1% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2023
Q1 2023 -$100M -$23.4M -$1.99M -9.3% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2023
Q4 2022 -$98M -$29.3M -$11.6M -65.2% 01 Oct 2022 31 Dec 2022 10-K 23 Feb 2023
Q3 2022 -$86.5M -$21.6M -$1.16M -5.7% 01 Jul 2022 30 Sep 2022 10-Q 08 Nov 2022
Q2 2022 -$85.3M -$25.7M -$7.59M -41.8% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023
Q1 2022 -$77.7M -$21.4M -$5.99M -38.8% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023
Q4 2021 -$71.7M -$17.7M -$5.6M -46.2% 01 Oct 2021 31 Dec 2021 10-K 23 Feb 2023
Q3 2021 -$66.1M -$20.4M -$11.8M -137% 01 Jul 2021 30 Sep 2021 10-Q 08 Nov 2022
Q2 2021 -$54.3M -$18.2M -$5.72M -46.1% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022
Q1 2021 -$48.6M -$15.4M -$7.01M -83.2% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022
Q4 2020 -$41.6M -$12.1M -$8.66M -250% 01 Oct 2020 31 Dec 2020 10-K 12 Mar 2021
Q3 2020 -$32.9M -$8.6M -$4.15M -93.4% 01 Jul 2020 30 Sep 2020 10-Q 04 Nov 2021
Q2 2020 -$28.8M -$12.4M -$6.25M -101% 01 Apr 2020 30 Jun 2020 10-Q 11 Aug 2021
Q1 2020 -$22.5M -$8.43M -$4.22M -100% 01 Jan 2020 31 Mar 2020 10-Q 11 May 2021
Q4 2019 -$18.3M -$3.46M 01 Oct 2019 31 Dec 2019 10-K 12 Mar 2021
Q3 2019 -$4.45M 01 Jul 2019 30 Sep 2019 10-K 12 Mar 2021
Q2 2019 -$6.19M 01 Apr 2019 30 Jun 2019 10-K 12 Mar 2021
Q1 2019 -$4.21M 01 Jan 2019 31 Mar 2019 10-K 12 Mar 2021

Bruker Cellular Analysis, Inc. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$98M -$26.3M -36.7% 01 Jan 2022 31 Dec 2022 10-K 23 Feb 2023
2021 -$71.7M -$30.1M -72.5% 01 Jan 2021 31 Dec 2021 10-K 23 Feb 2023
2020 -$41.6M -$23.3M -127% 01 Jan 2020 31 Dec 2020 10-K 23 Feb 2023
2019 -$18.3M +$5.04M +21.6% 01 Jan 2019 31 Dec 2019 10-K 28 Feb 2022
2018 -$23.3M 01 Jan 2018 31 Dec 2018 10-K 12 Mar 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.